If you haven't already read the first part of this topic, Language, Part I, you should go read that first. It gives the context for this post and some necessary background. In that first post, I talked about the first of two scenarios where the language utilized in responses to a vulnerable post was (or … Continue reading Language, Part II →

"Tumor Heterogeneity" (TH) is a phrase that often comes up in discussions with my medical team and with researchers as we all attempt to understand and anticipate the behavior of the cancer cells. From some of my discussions with other patients on social media, there does seem to be a lot of confusion about this … Continue reading Tumor Heterogeneity →

A little while ago, I wrote a post for SurvivingBreastCancer.org about genetic and genomic mutations, exploring some of the information we learned about my original breast tumor in 2017 and highlighting the differences between genetic and genomic testing. You can access that article here. As an aside SBC is a great resource for those newly … Continue reading Mutations become Targets →

Tomorrow I will start the IV chemo, Taxotere, along with the oral medication, Xeloda. This combination is designed to work together and gives my medical oncologist some flexibility. While I get the need to get ahead of the cancer cells that were not materially affected by my last line of treatment, the knowledge that I … Continue reading Heading into Chemo →